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Introduction
Spinal muscular atrophy (SMA) is a genetic disorder associated with recessive loss-of-function mutations in the human survival motor neurons 1 (SMN1) gene (Lefebvre et al., 1995) . SMA is a broad-spectrum disorder whose severity is inversely proportional to levels of full-length SMN protein (Nicole et al., 2002) . The most severe form of SMA is also the most common one, and these patients typically die within the fi rst 2 yr of life (Ogino and Wilson, 2004) . SMA is characterized by loss of motoneurons from the anterior horn of the spinal cord and progressive muscular atrophy in the limbs and trunk, usually culminating in respiratory failure (Ogino and Wilson, 2004) .
SMN is the central member of a large oligomeric protein complex implicated in a variety of subcellular processes, including pre-mRNA transcription and splicing, RNP biogenesis and transport, neuritogenesis, and axonal pathfi nding, as well as in the formation and function of neuromuscular junctions (Briese et al., 2005; Eggert et al., 2006) . However, the only SMN function that has been well-documented to date is its role in the biogenesis of Sm-class small nuclear RNPs (snRNPs; Fischer et al., 1997; Meister et al., 2001; Pellizzoni et al., 2002) . Despite the observation that SMA patient-derived SMN1 mutations lead to defects in Sm-core assembly in vitro (Shpargel and Matera, 2005; Wan et al., 2005; Winkler et al., 2005) , a defi nitive link between snRNP biogenesis and the etiology of the disease has not been established in a model organism.
Null mutations in single-copy SMN genes are lethal in every organism studied to date (Monani, 2005) . In humans and higher primates, there are two SMN genes, SMN1 and SMN2 (Courseaux et al., 2003) . SMN2 is dispensable, but can partially compensate for homozygous loss of SMN1 (Monani, 2005) . Patients with additional copies of SMN2 display milder phenotypes, a fi nding that has been confi rmed using several transgenic mouse models (Monani, 2005) . Because SMA is caused by reduced expression of SMN, modeling SMA in other genetically tractable organisms has been hampered by the need to create hypomorphic mutations. We describe the generation of a Drosophila melanogaster model of SMA. Hypomorphic Smn mutants are characterized by an inability to fl y or jump, and they display severe neuromuscular defects. The analysis of this phenotype has led to the surprising discovery that SMN is a sarcomeric protein, implicating a muscle-specifi c function.
A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle T.K. Rajendra, Graydon B. Gonsalvez, Michael P. Walker, Karl B. Shpargel, Helen K. Salz, and A. Gregory Matera Department of Genetics, Case Western Reserve University School of Medicine, Cleveland, OH 44106 M utations in human survival motor neurons 1 (SMN1) cause spinal muscular atrophy (SMA) and are associated with defects in assembly of small nuclear ribonucleoproteins (snRNPs) in vitro. However, the etiological link between snRNPs and SMA is unclear. We have developed a Drosophila melanogaster system to model SMA in vivo. Larval-lethal Smn-null mutations show no detectable snRNP reduction, making it unlikely that these animals die from global snRNP deprivation. Hypomorphic mutations in Smn reduce dSMN protein levels in the adult thorax, causing fl ightlessness and acute muscular atrophy. Mutant fl ight muscle motoneurons display pronounced axon routing and arborization defects. Moreover, Smn mutant myofi bers fail to form thin fi laments and phenocopy null mutations in Act88F, which is the fl ight muscle-specifi c actin isoform. In wildtype muscles, dSMN colocalizes with sarcomeric actin and forms a complex with α-actinin, the thin fi lament crosslinker. The sarcomeric localization of Smn is conserved in mouse myofi brils. These observations suggest a muscle-specifi c function for SMN and underline the importance of this tissue in modulating SMA severity.
Smn (CG16725) is a single-exon gene in D. melanogaster ( Fig.  1 A) , encoding a 226-aa protein (Miguel-Aliaga et al., 2000) . The expression profi le shows that dSMN is highly expressed during embryogenesis, but that the levels decrease sharply during subsequent developmental stages ( Fig. 1 B and not depicted). Because SMN is essential for Sm-core RNP assembly in human cells (Shpargel and Matera, 2005; Wan et al., 2005; Winkler et al., 2005) , we investigated whether the D. melanogaster protein has a similar conserved function. Schneider 2 (S2) cells treated with double-stranded RNA (dsRNA) targeting Smn, but not LacZ, were effi ciently and specifi cally depleted of dSMN (Fig. 1 C) . As assayed by two independent methods, Smn dsRNA-treated S2 cells were defi cient in assembly of new Sm cores (Figs. 1, D and E) . Thus, we conclude that SMN's function in snRNP assembly is conserved in invertebrates.
Characterization of Smn-null mutants
A previous study identifi ed two missense mutations (Smn A and Smn B ; Fig. 1 A) in the conserved Y-G box of the D. melanogaster gene, the homozygous inheritance of which results in late-larval lethality (Chan et al., 2003) . To identify additional alleles, we searched transposon insertion databases and found one P element and two piggyBac transposon insertions in both coding and noncoding regions of Smn (Fig. 1 A) . EY14384 (henceforth referred to as Smn E ) is a P insertion located 94 bp upstream of the putative transcription start site, whereas f05960 (Smn C ) and are missense mutations in the conserved Y-G box described previously (Chan et al., 2003 . (B) Western blot of embryonic and adult lysates. A dilution series of the embryonic lysate indicated that adults have ‫-03ف‬fold less dSMN than embryos. Anti-SNF antibody was used as the loading control. (C) S2 cells were left untreated (Mock) or incubated with dsRNAs targeting either LacZ or Smn. Cytoplasmic extracts were collected 3 d after treatment, and Western blotting confi rmed effi cient knockdown of dSMN compared with the loading control. (D) Radiolabeled U1 snRNA transcripts were incubated in cytoplasmic extracts and immunoprecipitated with α-Sm monoclonal antibody Y12 to assay for Sm-core assembly. Incubations of wild-type U1 snRNA (+) at the nonpermissive temperature (4°C) or a U1 construct containing a deletion in the Sm protein binding site (∆) at the permissive temperature (22°C) served as the negative controls. RNAi knockdown of dSMN significantly disrupted Sm-core assembly compared with mock and LacZ dsRNA transfections. (E) After dsRNA treatment for 6 d (two doses of dsRNA), S2 cells were transfected with either GFP alone or GFP-SmB. Immunoprecipitation using anti-GFP antibodies, followed by Northern analysis of U1 and U2 snRNAs, indicated that GFP alone did not bring down detectable amounts of snRNA, the amounts immunoprecipitated by GFP-SmB after RNAi knockdown of dSMN were at least twofold less than in the control (LacZ) knockdown. (F) Expression profi le of dSMN in the lethal alleles described in A. All of the lethal alleles are essentially protein nulls, although residual levels of dSMN in lysates derived from the Smn A and Smn B alleles varied from preparation to preparation (not depicted). Anti-SNF antibody was used as the loading control. We note that wild-type embryonic lysates were competent for the Sm-core assembly assay shown in D, but larval, pupal, and adult lysates were incompetent, which is consistent with previous results from other species (Gabanella et al., 2005; Wan et al., 2005 Importantly, transgenic expression of a UAS-YFP-Smn construct under control of a daughterless-GAL4 driver completely rescued the larval lethality of the two alleles we tested, producing viable adults. Thus, the A-D alleles are genetic-null mutants. Consistent with these genetic results, Western blotting of lysates from the phenocritical phase (second to third instar) indicated a complete loss of dSMN protein ( Fig. 1 F and not depicted) . However, despite the loss of dSMN, we could detect no appreciable differences in spliceosomal snRNA levels in the mutant larvae ( Fig. 1 G and Fig. S1 , available at http://www.jcb.org/cgi/ content/full/jcb.200610053/DC1). These fi ndings are similar to those of Wan et al. (2005) , which showed that reduced SMN expression and impaired snRNP synthesis caused a slow growth phenotype, but did not affect steady-state snRNP levels in chicken DT40 cells. Thus, despite the observation that dSMN functions in snRNP biogenesis in D. melanogaster, the lethality associated with the null mutants is not caused by a systemic depletion of snRNPs. SMA is caused by reduced levels of SMN in mammals; complete loss of function results in early lethality (Monani, 2005) . To generate a better D. melanogaster model for SMA, we screened for neuromuscular phenotypes in adult fl ies by imprecise excision of the P element in Smn E . From a total of ‫071ف‬ independent excisions, we isolated two lines (Smn E2 and Smn
E33
) that displayed overt motor dysfunction. Smn E2 and Smn E33 homozygotes (henceforth referred to as E2 and E33 mutants, respectively) each showed marked defects in fl ying and jumping. The E2 mutants exhibited a 2-d delay in pupation, refl ecting an extended larval period, and ‫%02ف‬ of the E2 pupae died at the pharate adult stage. However, the phenotype of the E2 mutants was incompletely penetrant; ‫%54ف‬ of E2 animals had fl ight and jump defects. Moreover, dSMN expression levels in these animals were also variable (unpublished data). In contrast, E33 mutants were completely viable and fertile, and 100% of the animals were incapable of fl ying or jumping (Videos 1 and 2, available at http://www.jcb.org/cgi/content/full/jcb.200610053/DC1). Because the E33 phenotype was fully penetrant, this allele was chosen for further characterization.
The indirect fl ight muscles (IFMs) of the D. melanogaster thorax are among the best characterized muscles in the adult animal and are essential for fl ight (Fernandes and Keshishian, 1999) . Because E33 mutants are fl ightless, we prepared hemithoraces by dissection and analyzed the IFMs of wild-type and mutant animals by light microscopy. The IFMs of the fruitfl y are composed of dorsal longitudinal muscles (DLMs) and dorsoventral muscles (DVMs). The mutant IFMs were highly disorganized, even when observed at a gross level (Fig. 2 A) .
Although DLM fi bers in wild-type fl ies span the entire anteroposterior length of the dorsal thorax, E33 DLMs often failed to extend the whole length of the thorax, and DVMs were typically unidentifi able (Fig. 2 A) . When salicylate-cleared thoraces were imaged under plane-polarized light, signifi cant muscle degeneration was apparent in the mutant fi bers (Fig. 2 B) . Under higher magnifi cation, wild-type IFMs showed the characteristic Figure 2 . Phenotypic analysis of Smn E33 hypomorphs. (A) Light microscopic analysis of hemithoraces from 2-3-d-old wild-type (WT, left) and E33 mutant IFMs showed considerable disorganization of muscle fi bers (middle and right). (B) Thoraces were visualized under plane-polarized optics after clearing in methylsalicylate. The IFMs consist of two groups, the DLMs and the DVMs. DLMs run from anterior to posterior on the dorsal side of the thorax, and DVMs run dorsoventrally, nearly perpendicular to the DLMs. Wild-type muscles appear normal (left), including the tergal depressor of the trochanter (jump) muscle, outlined in white and below the plane of the DLMs. Mutant fi bers showed clear signs of degeneration (dark patches within the muscle). Both DLMs and DVMs were equally and severely affected; however, the jump muscles displayed normal (center) to severe (right) degeneration phenotypes. (C) Higher magnifi cation view of wild-type (WT) and E33 mutant DLMs showing striations in the wild type that are absent from the mutant myofi bers. (D and E) Western blotting of dSMN from embryonic, pupal, total adult, or total adult thoracic lysates. Although no major differences in dSMN levels were detected in the total lysates at any of the developmental stages, dSMN was markedly reduced in E33 mutant thoraces (two different preparations are shown) compared with either wild type or the parental Smn E line. Antibodies against SmB (Y12) and SNF were used as loading controls. Molecular weight markers are in kilodaltons.
striations, whereas the mutant muscles were extremely irregular, with numerous bulges and constrictions throughout (Fig.  2 C) . Thus, E33 mutants display severe muscular atrophy, which is one of the hallmark features of SMA.
Genetic complementation analyses revealed that the lossof-function (null) alleles, described in the previous section ( Fig.  1 A) , each failed to complement the motor dysfunction phenotype of the E33 allele. Furthermore, the fl ightlessness of the E33 mutation was rescued by expression of the UAS-YFP-Smn transgene under the control of a daughterless-GAL4 driver, demonstrating that the observed motor defects in E33 are, indeed, caused by loss of dSMN function. Therefore, we were somewhat surprised when we analyzed developmentally staged lysates by Western blotting of dSMN and found no appreciable differences between adult wild-type and E33 mutants (Fig.  2 D) . Upon further analysis, we found that the amount of dSMN produced in the mutant thoraces was substantially reduced relative to either wild-type or Smn E parental lines (Fig. 2 E) . Although the reason for this tissue-specifi c depletion is currently unknown, the mutants presented us with an opportunity to analyze the neuromuscular defects associated with reduced dSMN expression.
During the embryonic-larval transition, D. melanogaster motoneurons contact muscle fi bers only after the completion of myogenesis (Johansen et al., 1989) . In contrast, adult motoneurons establish contact with the developing muscle fi bers during myogenesis, which is a situation more akin to that of vertebrate development (Fernandes and Keshishian, 1999) . Fruitfl y DLMs are innervated by remodeled larval motoneurons whose cell bodies lie within the thoracic ganglion and project dorsally into the fl ight muscles (Fernandes and Keshishian, 1999) . Using monoclonal antibody 22C10, which stains neuronal processes (Patel, 1994) , we analyzed the DLMs of E33 hypomorphs for defects in the organization of their DLM motoneurons. As shown in Fig. 3 , both the number and routing of primary motoneuron branches was clearly compromised in E33 fl ies, as compared with controls. Secondary branches were disorganized (Fig. 3) and arborization defects ranged from moderate to severe. Because the mutant muscle fi bers were spatially disorganized, it was diffi cult to assign parameters to the individual motoneurons. Using criteria established by Hebbar and Fernandes (2004) as a guide, we scored fl ies from each genotype and found that ‫%08ف‬ of the mutant thoraces showed motoneuron routing defects; a smaller fraction ‫)%04ف(‬ showed defects in secondary branching and arborization. No such defects were observed in the control animals. Thus, we conclude that reduced thoracic Smn expression leads to acute neuromuscular dysfunction in D. melanogaster.
Smn is required for Actin88F expression
The development of muscles and motoneurons in the adult fruitfl y are spatiotemporally associated. In other words, the synthesis of structural proteins important for one tissue can require the presence of the other tissue. For example, formation of the male-specifi c muscle (MSM) and the development of its specialized characteristics are absolutely dependent on innervation (1°) grow out from the main nerve trunk (N) that traverses the length of the six adult DLM fi bers. Defasciculation of primary branches leads to establishment of secondary (2°) and tertiary (3°) branches, which develop the terminal arbor (not depicted). DLM motoneurons were stained with monoclonal antibody 22C10, which stains neuronal processes. Organization of primary branches in both the wild-type and the parental Smn E animals appeared normal. The number and routing of primary motoneuron branches were severely compromised in E33 fl ies. (B) Quantitation of routing and branching defects in wild-type and mutant DLMs. Primary branches that displayed a meandering path were taken as having routing defects. Motoneurons displaying fewer than three secondary branches were scored as having a secondary branching defect (wild-type animals display a minimum of four to fi ve secondary branches). 90 hemithoraces (from 90 individual fl ies) of each genotype were scored. (Currie and Bate, 1995) . Furthermore, expression of an MSMspecifi c actin isoform, Act79B, is also dependent on innervation (Currie and Bate, 1995) . Similarly, in vertebrates, denervation is known to result in reduced expression of skeletal muscle actin (Shimizu et al., 1988) . Given that SMA is characterized by motoneuron denervation, it seemed likely that the neuromuscular defects observed in the E33 hypomorphs was also coupled with innervation failure. Because one of the hallmarks of innervation failure is reduced expression of actin, we tested whether the IFM-specifi c actin isoform Act88F (Fyrberg et al., 1983) was expressed in the Smn hypomorphs. RT-PCR was performed on thoracic RNA from wild-type, Smn E , and E33 animals, using primers specifi c for Act88F, Tropomyosin 2 (Tm2), and Troponin I (TnI) transcripts. Expression of Act88F was undetectable in the mutant thoraces, whereas the transcripts were easily detected in the wild-type and Smn E strains (Fig. 4 A) . We note that loss of Act88F expression was not caused by a general loss of transcription or splicing in the IFMs, as the RT-PCR products for TnI and Tm2 (which cross intron-exon boundaries) were comparable in all three samples (Fig. 4 A) . Consistent with the idea that splicing is unaffected in the mutants, Northern analysis of thoracic lysates from wild-type or E33 fl ies showed no signifi cant differences in steady-state levels of either snRNAs (Fig. 4 B) or trimethylguanosine-capped snRNPs (Fig. S1) . Staining of wild-type (Fig. 4 C) and mutant (Fig. 4 D) muscles with phalloidin confi rmed the general loss of fi lamentous actin in the hypomorphic IFMs. Most importantly, actin staining and proper myofi bril formation were rescued by transgenic expression of YFP-dSMN (Fig. 4 E) . Thus, reduced levels of dSMN protein result in loss of Act88F expression and severe neuromuscular disorganization.
SMN interacts with -actinin
In a parallel set of experiments, we were interested in purifying and characterizing the D. melanogaster SMN complex. After transient transfection of S2 cells with a Flag-dSMN construct, we performed a pulldown experiment with anti-Flag beads. Associated proteins were eluted from the beads by boiling in sample buffer and subjected to SDS-PAGE. The protein profi les of transfected versus nontransfected cells were compared by RT-PCR analysis of IFM-specifi c actin (Act88F) expression; transcripts were not detectable in E33 mutants, whereas expression was normal in the wild-type (WT) and the parental Smn E alleles. Troponin I (TnI) and tropomyosin 2 (Tm2) RT-PCR products served as internal controls. (B) Northern blot of total thoracic RNA from adult wild-type (WT) or E33 mutants shows that steady-state U1 and U2 snRNA levels are normal. U3 and U6 snRNA levels used as loading controls. 2 μg of total RNA were loaded in each lane. (C-E) Loss of actin expression was confi rmed in E33 mutant myofi bers using phalloidin. Whereas the characteristic repetitive blocks of actin were observed in wild-type (WT) myofi brils (c), no staining was detected in the mutant (d). Actin staining in the E33 mutants was restored by transgenic expression of YFP-dSMN (E). Molecular weight markers in base pairs. (A) FlagdSMN was transiently transfected into S2 cells and purifi ed over anti-FLAG beads. Eluted proteins were subjected to SDS-PAGE and Coomassie staining. Untransfected cells were used as a negative control. The three marked bands were excised from the gel and identifi ed by mass spectrometry as α-actinin, Flag-dSMN, and dSMN, respectively. (B) Pulldown assays with GST-dSMN or GST alone were performed using total adult lysates. The pulldowns were assayed by Western blotting with monoclonal α-actinin antibodies. Polyclonal anti-GST antibodies were used for the loading controls. (C) Proteins were coimmunoprecipitated from adult thoracic lysates with dSMN antibodies and analyzed by Western blotting with α-actinin antibodies. Molecular weight markers in kilodaltons.
Coomassie staining (Fig. 5 A) . Although a more detailed analysis (unpublished data) suggests that there are likely to be many other differences between the two samples, three prominent bands could be easily distinguished. The bands were excised from the gel and analyzed by mass spectrometry. The two smaller proteins were identifi ed as Flag-dSMN and endogenous dSMN (Fig. 5 A and not depicted) . Because SMN is known to self-oligomerize (Lorson et al., 1998) , we expected to recover the endogenous dSMN protein. However, the third, ‫-001ف‬kD band was identifi ed by 39 distinct peptides in the mass spectrogram as D. melanogaster α-actinin (Fig. S2 , available at http:// www.jcb.org/cgi/content/full/jcb.200610053/DC1).
Because α-actinin is a protein known to play a major role in cross-linking actin fi laments within numerous cell types, including muscle (Clark et al., 2002) , we tested whether dSMN interacts with α-actinin in additional biochemical assays. We performed GST-pulldown and coimmunoprecipitation analyses using adult and thoracic lysates. Fig. 5 B shows that α-actinin was recovered using GST-dSMN, but not with GST alone (control). As shown in Fig. 5 C, anti-dSMN antibodies weakly, but reproducibly, coprecipitated α-actinin. Control (anti-myc) antibodies and beads coprecipitated only background amounts of α-actinin. Collectively, these studies show that dSMN forms a complex with α-actinin in vivo.
SMN localizes to IFM myofi brils
Given the aforementioned fi ndings, we analyzed the localization of dSMN in the IFMs of wild-type and YFP-dSMN transgenic fl ies (Fig. 6) . Each IFM myofi ber is a single multinucleate cell composed of several myofi brils that contain numerous functional units called sarcomeres. Within each sarcomere, actin (thin) and myosin (thick) fi laments interdigitate to form contractile elements. Thick fi laments are anchored together within a structure known as the M-line, whereas thin fi laments are anchored at the Z-line or Z-disc (Clark et al., 2002) . The region between the M-lines is called the I-band. Actin is typically excluded from the M-line, localizing throughout the I-band, and it is often enriched at, or depleted from, the Z-line.
In wild-type and YFP-dSMN transgenic myofi bers, dSMN was detected not only in muscle cell nuclei but also in the individual myofi brils (Fig. 6 , E and F; and not depicted). Within the myofi brils, three distinct patterns of sarcomeric localization were observed: I-band, Z-line enriched, and granular (Fig. 6 , A-C). The same three SMN localization patterns were visible in IFM myofi brils from YFP-dSMN transgenic fl ies (Fig. 6 , J-L). The I-band pattern was the predominant one, as confi rmed by phalloidin costaining (Fig. 6, G-I) . However, the dSMN and actin staining patterns did not always correlate, especially in respect to accumulation at the Z-line. That is, when actin was enriched at the Z-line, dSMN did not necessarily show a similar enrichment, and vice versa. It is possible that dSMN localization within the sarcomere is dynamic; future experiments will be required to address this point. Meanwhile, control antibodies and secondary antibodies alone clearly failed to stain the sarcomeres (Fig. 6, D and F) . Similarly, a 2xYFP transgene construct showed only background staining in the myofi brils (Fig. 6 M) . Importantly, in myofi brils where dSMN was enriched at the Z-line, it colocalized with α-actinin (Fig. 6, N and O) . We conclude that dSMN localizes to fl ight muscle sarcomeres.
Smn hypomorphs phenocopy Act88F-null mutants
The studies detailed in the previous sections suggested that the fl ightlessness associated with the Smn E33 allele might be caused by a loss of actin expression in the IFMs. Therefore, we examined the IFMs of fl ies that contain a null mutation in Act88F (Okamoto et al., 1986) , which is called KM88. Like Smn E33 mutants, Act88F
KM88 homozygotes are fl ightless and fail to form proper IFMs, but are otherwise viable and fertile (Okamoto et al., 1986) . As shown in Fig. 7 A, KM88 mutants express dSMN, but the protein is delocalized. Similarly, α-actinin, an actin fi lament cross-linking factor (Otey and Carpen, 2004) , was mislocalized in both the Smn and the Act88F mutant backgrounds, which is consistent with a complete failure to form thin fi laments.
Further analysis demonstrated that thick fi lament formation was largely unperturbed in the Smn hypomorphic IFMs, and that α-actinin staining did not overlap with the myosin fi laments (Fig. 7 B) . This scenario is, again, very similar to that of the KM88 mutation, wherein the vast majority of myosinpositive fi laments are devoid of α-actinin (unpublished data). Collectively, these fi ndings indicate that dSMN and Act88F are required for proper formation of fl ight-muscle myofi brils.
Smn localization to sarcomeres is evolutionarily conserved
To determine whether the sarcomeric localization of SMN is a conserved feature among vertebrates, we prepared myofi brils from mouse hindlimb muscles and analyzed the distribution of Smn and α-actinin. As shown in Fig. 8 , Smn colocalizes with α-actinin in a Z-line pattern. Two independent anti-SMN antibodies revealed the same pattern, and control antibodies were negative (Fig. 8) . Unlike the situation in the fl y, mouse Smn localized exclusively to the Z-line; no granular or I-band like patterns were observed.
In summary, four lines of evidence demonstrate that SMN is a bona fi de sarcomeric protein. First, localization to the sarcomere was not simply caused by cross-reactivity of the antibodies, as transgenic expression of YFP-dSMN showed pro minent myofi brillar staining that was completely absent in control IFMs (Fig. 6) . Second, control antibodies fail to stain the sarcomeres of both fl ies and mice (Figs. 6 and 8) . Third, dSMN staining was lost in the E33 mutants, resulting in a loss of Act88F expression and thin fi lament formation (Fig. 4) . Fourth, dSMN interacts with α-actinin in vitro and in vivo (Fig. 5) , and reduced dSMN expression leads to complete disorganization of α-actinin in situ (Fig. 7 B) . Thus, we conclude that SMN is a sarcomeric protein.
Discussion

SMN and the etiology of SMA
Despite the well-established gene-disease relationship between SMN1 and SMA, the connection between protein function and molecular etiology has been obscured by a plethora of putative cellular functions attributed to SMN (Briese et al., 2005; Eggert et al., 2006) . Previous investigations have shown that the SMN complex is required for assembly and transport of spliceosomal snRNPs (Fischer et al., 1997; Meister et al., 2001; Pellizzoni et al., 2002; Narayanan et al., 2004; Shpargel and Matera, 2005) . Additional fi ndings point to roles for this complex in neurite outgrowth and pathfi nding (Fan and Simard, 2002; McWhorter et al., 2003; Sharma et al., 2005) , neuromuscular junction formation (Chan et al., 2003) , profi lin binding (Giesemann et al., 1999; Sharma et al., 2005) , and axonal transport of β-actin mRNPs (Rossoll et al., 2003) . A common link between each of these additional studies is the actin cytoskeleton. Our fi nding that reduced dSMN expression leads to motor axon routing and arborization defects, coupled with a loss of Act88F expression in the muscle, is consistent with this actin-related theme.
A muscle-specifi c function for SMN
The vast majority of SMA studies continue to be focused on a motoneuron-specifi c role for SMN; our results do not exclude such a function. However, the idea that SMN might also have a muscle-specifi c function is not a new one. Cocultures of SMA type I and II muscles with wild-type motoneurons failed to sustain innervation, whereas muscles from control or SMA type III patients maintained stable connections, suggesting a musclespecifi c requirement for SMN (Braun et al., 1995; GuettierSigrist et al., 2002) . Similarly, down-regulation of Smn in mouse C2C12 cells revealed defects in myoblast fusion (Shafey et al., 2005) and tissue-specifi c knockouts of Smn in mouse muscle resulted in pronounced dystrophic phenotypes (Cifuentes-Diaz et al., 2001; Nicole et al., 2003) . Also in support of a musclespecifi c function is the observation that, despite having comparable levels of SMN, mouse skeletal muscle extracts failed to support effi cient Sm-core assembly, whereas extracts from spinal cord were quite active (Gabanella et al., 2005) . Collectively, these studies show that relatively high levels of SMN are required in muscles, although the reason for this requirement was unclear.
Our discovery that SMN is a sarcomeric protein required for expression of muscle-specifi c actin not only provides a plausible role for the protein in muscles, but highlights the potential importance of this tissue in SMA pathophysiology. At least 20 different skeletal muscle diseases are thought to be caused by mutation or mislocalization of sarcomeric proteins (Sarnat, 1992; Hauser et al., 2000; Moreira et al., 2000; Selcen and Engel, 2003; Laing and Nowak, 2005) . In this regard, it is parti cularly interesting that SMA patients have been shown to display varying degrees of myofi brillar/sarcomeric (including Z-line) abnormalities (Szliwowski and Drochmans, 1975; Braun et al., 1995) . Notably, αB-crystallin was recently reported to form a complex with SMN in HeLa cells (den Engelsman et al., 2005) . αB-crystallin is an intermediate fi lament protein that, in muscle cells, accumulates at the Z-line (Laing and Nowak, 2005) . Thus, the SMN complex can interact with at least two distinct Z-line proteins, α-actinin, and αB-crystallin.
We have shown that reduced thoracic dSMN levels result in loss of Act88F expression with no apparent defect in either snRNP biogenesis or pre-mRNA splicing. Because expression of muscle-specifi c actin is known to be dependent on motoneuron innervation (Shimizu et al., 1988; Currie and Bate, 1995) , the neuronal defects observed in the Smn E33 hypomorphs are consistent with those expected of an SMA model. Further, the data are consistent with denervation as either the cause or a consequence of muscle degeneration. Notably, a fraction of SMA type III patients display dystrophic phenotypes without evidence of neurogenic abnormalities (Szliwowski and Drochmans, 1975; Vajsar et al., 1998; Muqit et al., 2004) . Although motoneuron loss is generally regarded as a late event in disease progression, one of the main problems in studying SMA, especially the severe forms, is that we are only able to analyze the end-stage of the disease.
We currently do not know whether the mutant phenotype observed in the Smn hypomorphs is caused by reduced dSMN expression in the thoracic muscles, the motoneurons, or a combination of tissues. Future work using tissue-specifi c rescue constructs and a detailed analysis of motoneuron development and myogenesis in the Smn hypomorphic pupae will address these important issues. Regardless of the actual disease trigger, the identifi cation of SMN as a sarcomeric protein underscores the importance of muscle cell function in modulating the severity of SMA. Bellen et al., 2004) . Excision alleles were generated by mobilization of the Smn E P element using standard protocols. KM88 was a gift from J. Vigoreaux (University of Vermont, Burlington, VT). All stocks were cultured on standard cream-of-wheat agar at room temperature (24 ± 1°C) in half-pint bottles. Genetic complementation analyses were performed using standard methods. UAS-2xEYFP, which was used as control for nonspecifi c localization, and the daughterless-Gal4 (da-Gal4) lines were obtained from the Bloomington Stock Center. For rescue experiments, a YFP-dSMN transgene (a gift from J. Gall, Carnegie Institution of Washington, Baltimore, MD) was expressed under the control of da-Gal4 in the following homozygous backgrounds: Smn E33 , Smn A , and Smn B .
Materials and methods
Fly stocks and genetics
Western blotting
Embryonic, larval, adult (total and thoracic), and S2 cell lysates were prepared, electrophoresed, and blotted using standard protocols. Anti-rabbit dSMN antibody (a gift from J. Zhou, University of Massachussetts Medical School, Worcester, MA) was affi nity-purifi ed and used at a dilution of 1:10,000. Antibodies against SNF (4G3, monoclonal), SmB (Y12, monoclonal), and tubulin (anti-rabbit; Sigma-Aldrich) were used as loading controls. Appropriate HRP-conjugated secondary antibodies were used for detection.
snRNP assembly assay
Smn and LacZ dsRNAs were transcribed in vitro from PCR products fl anked with T7 promoters. D. melanogaster S2 cells were placed in SF-900 media containing 14 μg/ml of dsRNA. Extracts were generated 3 d after dsRNA treatment using the Ne-Per nuclear/cytoplasmic extraction kit (Pierce Chemical Co.) and dialyzed in reconstitution buffer (20 mM Hepes-KOH, pH 7.9, 50 mM KCl, 5 mM MgCl 2 , and 0.2 mM EDTA) as previously described (Pellizzoni et al., 2002) . 40 μg of cytoplasmic extract were loaded on a gel for Western blotting to confi rm knockdown. For the assembly assay, wild-type D. melanogaster U1 snRNA and U1 snRNA containing a deletion of the Sm assembly site were in vitro transcribed from PCR products in the presence of [ 32 P]UTP and m7G cap analogue (Promega). 100,000 counts of radiolabeled U1 snRNA were incubated in 100 μg of cytoplasmic extract at 22°C for 40 min in reconstitution buffer. Assembled snRNPs were precleared with protein G beads before immunoprecipitation with monoclonal antibody Y12 in RSB-100 buffer (600 mM NaCl, 20 mM Tris-HCl, pH 7.4, 2.5 mM MgCl 2 , and 0.01% NP-40; Pellizzoni et al., 2002) . Immunoprecipitated RNAs were denatured in formamide loading buffer, run on a 6% acrylamide TBE-urea gel, and exposed to a phosphorimager.
GST pulldown assay GST-dSMN was cloned as previously described (Ilangovan et al., 2003) . Total fl y lysate was homogenized in NET buffer (150 mM NaCl, 50 mM Tris, pH 7.5, and 5 mM EDTA). 500 μg of lysate was passed over recombinant 8 μg GST or GST-dSMN beads overnight in NET buffer. The pulldown products were washed and loaded on a denaturing gel.
IP-Northern
15 μg of dsRNA against Smn or LacZ (control) were added twice to S2 cell medium over a course of 6 d. After knockdown, cells were transfected with GFP-SmB. Northern blotting of GFP-SmB immunoprecipitate using radiolabeled D. melanogaster U1 and U2 snRNA probes was performed following established protocols.
Northern blotting
Total RNA from adult thoraces was extracted using TRIZOL (Invitrogen). Adult thoraces were pulled apart from the main body, and wings and legs were clipped close to the thorax. Thoraces were immediately transferred to TRIZOL and homogenized. Total RNA was extracted following the manufacturer's instructions. RNA was run on a standard 10% polyacrylamideurea gel (Invitrogen), transferred to a nylon membrane, and probed with 32 P-labeled PCR products corresponding to the D. melanogaster U1, U2, and U6 snRNAs and U3 snoRNA.
RT-PCR
Total RNA from adult thoraces was prepared as described in the previous section. RT-PCR, with appropriate controls, was performed using SuperScript First-Strand synthesis system (Invitrogen). In brief, oligo-dT-primed fi rst-strand synthesis products were subjected to 20 cycles of PCR using gene-specifi c primers. Sequences are as follows: Act88F, sense 5′-C C A-
C G C C A T T C T G C G T C T G G -3′ and antisense 3′-G C T G C C T T T G A A G A G-C T T T C G C G -3′; troponin I, sense 5′-T T G T G A A G G C C A G A A A T G G G -3′ and antisense 5′-G A C T T C A T T T C T G A T C A A A T -CCAT; and tropomyosin 2, sense 5′-C A C C A T G G A C G C C A T C A A G A A G -3′ and antisense 5′-T T G G-T A T C G G C A T C C T C A G C -3′.
Immunostaining
The IFMs were dissected from the thorax with the help of fi ne forceps and needles in a drop of PBS. The entire muscle preparation was fi xed in 4% paraformaldehyde, and the fi bers were partially teased apart with needles. Immunofl uorescence was performed following established protocols. Certain preparations were also stained for fi lamentous actin by adding 1 μM FITC-conjugated phalloidin (Sigma-Aldrich) 20 min before the secondary antibody incubation was completed. Images were taken using either a TCS SP2 laser scanning confocal microscope or a DM6000 microscope (both Leica), and assembled using Photoshop (Adobe). The Leica Confocal Scanner is interfaced with Leica Confocal Software, and the DM6000 microscope is interfaced with Volocity software. Images were captured at room temperature using a 62× oil immersion objective.
YFP-dSMN localization
Wild-type and transgenic thoracic muscles were dissected in a drop of phosphate-buffered saline (PBS) and fi xed in 4% paraformaldehyde. Certain preparations were stained with 1 μM TRITC-phalloidin for 20 min to reveal fi lamentous actin. Teased myofi brils were washed in PBS and mounted in antifade (50% glycerol and 2.3% 1,4-diazobicyclo-2,2,2-octane). Images were obtained using a TCS SP2 laser scanning confocal microscope or DM6000 microscope, and assembled using Photoshop.
Motoneuron staining
Hemithoraces were generated by freezing in liquid nitrogen and dissecting with a razor blade along the central axis of the body. The bisection was slightly offset from the midline, so as to preserve the other half of the thorax intact. Tissues were then processed for immunostaining essentially as previously described (Hebbar and Fernandes, 2004) . During fi xation, IFMs of the bisected side were fl ipped over to expose the contralateral hemithorax. The routing of the primary axons and the number of secondary branches was quantitated as described in the text.
Analysis of IFMs
Hemithoraces were prepared as described in the previous section, and the thoraces were observed and imaged under bright-fi eld optics, with or without counterstaining with safranin for contrast. Analysis of muscles using plane-polarized optics was performed essentially as previously described (Nongthomba and Ramachandra, 1999) .
Preparation and staining of mouse myofi brils
Mouse skeletal myofi brils were prepared by the method of Knight and Trinick (1982) . In brief, hind leg skeletal muscles were depleted of calcium by incubating in an EGTA-Ringer's solution overnight at 4°C. The sample was placed in rigor buffer and homogenized using a glass Dounce tissue grinder. The homogenate was spun (2,000 g for 5 min) and washed in repeated cycles until a pure preparation of myofi brils (as monitored by phase-contrast microscopy) was obtained. Purifi ed myofi brils were adsorbed onto a gelatin-coated slide and subjected to immunofl uorescence analysis using standard protocols. Note that for dual staining of Smn and α-actinin, mouse monoclonal antibodies targeting a-actinin were incubated with the purifi ed myofi brils, followed by incubation with secondary antibodies conjugated to Alexa Fluor 594. After extensive washes, the preparations were incubated with FITC-conjugated monoclonal anti-SMN antibodies. Fig. S1 shows the analysis of snRNA and snRNP levels in wild-type and mutant animals. Fig. S2 shows the amino acid sequence of D. melanogaster α-actinin that was covered by mass spectrometric analysis of the band shown in Fig. 5 A. Videos 1 and 2 show the fl ight behavior of wild-type and E33 mutant adult fl ies, respectively. The online version of this article is available at http://www.jcb.org/cgi/content/full/jcb.200610053/DC1.
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